RNS Number : 7640I
Stenprop Limited
03 April 2020




(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP


("Stenprop" or the "Company")






3 April 2020


Shareholders are advised of the following information relating to the exercise of nil cost options under the Stenprop Amended Deferred Share Bonus Plan (the "Deferred Bonus Plan"), which vested on 31 March 2020:


Name of director:

James Beaumont

Transaction date:

31 March 2020

Class of securities:

Nil cost options

Number of securities exercised:


Deemed total value of the transaction:

GBP 7,114.86 (at a deemed value of GBP 0.94 per nil cost option)

Nature of transaction:


Nature and extent of director's interest:

Clearance to deal received:

Off-market exercise of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial



The Company intends to utilise treasury shares to settle the exercise of the nil cost options by James Beaumont and by other participants who also exercised nil cost options under the Deferred Bonus Plan on 31 March 2020. Following these transactions, the total number of treasury shares held by the Company will be 15,806,751 ordinary shares and the total number of shares in issue less shares held in treasury will be 282,968,424 ordinary shares.


For further information:


Stenprop Limited

Paul Arenson
Julian Carey

James Beaumont

44(0)20 3918 6600


Numis Securities Limited (Financial Adviser)

Hugh Jonathan
Vicki Paine

44(0)20 7260 1000


JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

27 (0) 11 722 3050


About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.